Corcept Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CORT

Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B. 

CEO
Joseph K. Belanoff
CEOJoseph K. Belanoff
Employees
730
Employees730
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
1998
Founded1998
Employees
730
Employees730

CORT Key Statistics

Market cap
10.15B
Market cap10.15B
Price-Earnings ratio
256.34
Price-Earnings ratio256.34
Dividend yield
—
Dividend yield—
Average volume
1.24M
Average volume1.24M
High today
$95.66
High today$95.66
Low today
$91.21
Low today$91.21
Open price
$91.50
Open price$91.50
Volume
161.80K
Volume161.80K
52 Week high
$95.66
52 Week high$95.66
52 Week low
$28.66
52 Week low$28.66

Stock Snapshot

The current Corcept Therapeutics(CORT) stock price is $94.58, with a market capitalization of 10.15B. The stock trades at a price-to-earnings (P/E) ratio of 256.34.

During the trading session on 2026-07-21, Corcept Therapeutics(CORT) shares reached a daily high of $95.66 and a low of $91.21. At a current price of $94.58, the stock is +3.7% higher than the low and still -1.1% under the high.

Trading activity shows a volume of 161.8K, compared to an average daily volume of 1.24M.

Over the past 52 weeks, Corcept Therapeutics(CORT) stock has traded between a high of $95.66 and a low of $28.66.

Over the past 52 weeks, Corcept Therapeutics(CORT) stock has traded between a high of $95.66 and a low of $28.66.

CORT News

Nasdaq 14h
Corcept's CFO Set His Selling Plan the Month the Stock Fell 50% — Here's What Investors Should Know

Key Points The transaction involved 40,000 shares with an estimated value of $3.5 million on the July 15, 2026 transaction date. The activity was executed thr...

Corcept's CFO Set His Selling Plan the Month the Stock Fell 50% — Here's What Investors Should Know
Nasdaq 14h
A Corcept Director Holds 1.5 Million Shares Through a 50% Crash and Rebound

Key Points The transaction involved the sale of 10,000 shares at $88.30 per share, resulting in a total value of $883,000 on July 15, 2026. The sale reduced t...

A Corcept Director Holds 1.5 Million Shares Through a 50% Crash and Rebound
Simply Wall St 3d
Corcept Therapeutics Stock Could Trade At A Discount As Its 346% Run Looms

Corcept Therapeutics has delivered very strong long term share price gains over the past five years, yet its latest valuation checks lean more cautious, leaving...

Corcept Therapeutics Stock Could Trade At A Discount As Its 346% Run Looms

People also own

Based on the portfolios of people who own CORT. This list is generated using Robinhood data, and it’s not a recommendation.
Novo Nordisk
Broadcom
Robinhood Markets
Palantir Technologies
Palo Alto Networks
Taiwan Semiconductor Manu…

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.